Authors: Thabard, W Collette, M Mellerin, MP Puthier, D Barille, S Bataille, R Amiot, M

Citation: W. Thabard et al., IL-6 upregulates its own receptor on some human myeloma cell lines, CYTOKINE, 14(6), 2001, pp. 352-356

Authors: Thabard, W Collette, M Bataille, R Amiot, M

Citation: W. Thabard et al., Protein kinase C delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cells, BIOCHEM J, 358, 2001, pp. 193-200

Authors: Puthier, D Thabard, W Rapp, MJ Etrillard, M Harousseau, JL Bataille, R Amiot, M

Citation: D. Puthier et al., Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule, BR J HAEM, 112(2), 2001, pp. 358-363

Authors: Barille, S Collette, M Thabard, W Bleunven, C Bataille, R Amiot, M

Citation: S. Barille et al., Soluble IL-6R alpha upregulates IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells, CYTOKINE, 12(9), 2000, pp. 1426-1429

Authors: Thabard, W Barille, S Collette, M Harousseau, JL Rapp, MJ Bataille, R Amiot, M

Citation: W. Thabard et al., Myeloma cells release soluble interleukin-6R alpha in relation to disease progression by two distinct mechanisms: Alternative splicing and proteolytic cleavage, CLIN CANC R, 5(10), 1999, pp. 2693-2697

Authors: Barille, S Thabard, W Robillard, N Moreau, P Pineau, D Harousseau, JL Bataille, R Amiot, M

Citation: S. Barille et al., CD130 rather than CD126 expression is associated with disease activity in multiple myeloma, BR J HAEM, 106(2), 1999, pp. 532-535